A business in context
GILD research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-22 | Burkhart Erin | F · Tax / exercise payment | Common Stock | 768.0 | 152.67 |
| 2026-09-22 | Burkhart Erin | M · Exercise / conversion | Common Stock | 2223.0 | n/a |
| 2026-09-22 | Burkhart Erin | M · Exercise / conversion | Restricted Stock Unit | 2223.0 | n/a |
| 2026-09-15 | Mercier Johanna | S · Sale | Common Stock | 1600.0 | 143.69 |
| 2026-09-15 | Mercier Johanna | S · Sale | Common Stock | 800.0 | 144.46 |
| 2026-09-15 | Mercier Johanna | S · Sale | Common Stock | 600.0 | 145.29 |
| 2026-09-15 | Dickinson Andrew D | S · Sale | Common Stock | 3000.0 | 145.29 |
| 2026-09-10 | Cain Wettan Keeley M | M · Exercise / conversion | Common Stock | 590.0 | n/a |
| 2026-09-10 | Cain Wettan Keeley M | F · Tax / exercise payment | Common Stock | 285.0 | 144.81 |
| 2026-09-10 | Cain Wettan Keeley M | M · Exercise / conversion | Restricted Stock Unit | 590.0 | n/a |
| 2026-09-10 | Mercier Johanna | M · Exercise / conversion | Common Stock | 2797.0 | n/a |
| 2026-09-10 | Mercier Johanna | F · Tax / exercise payment | Common Stock | 1347.0 | 144.81 |
| 2026-09-10 | Mercier Johanna | M · Exercise / conversion | Restricted Stock Unit | 2797.0 | n/a |
| 2026-09-10 | Berger Dietmar | F · Tax / exercise payment | Common Stock | 263.0 | 144.81 |
| 2026-09-10 | Berger Dietmar | M · Exercise / conversion | Common Stock | 533.0 | n/a |
| 2026-09-10 | Berger Dietmar | M · Exercise / conversion | Restricted Stock Unit | 533.0 | n/a |
| 2026-09-10 | O'Day Daniel Patrick | F · Tax / exercise payment | Common Stock | 4230.0 | 144.81 |
| 2026-09-10 | O'Day Daniel Patrick | M · Exercise / conversion | Common Stock | 8780.0 | n/a |
| 2026-09-10 | O'Day Daniel Patrick | M · Exercise / conversion | Restricted Stock Unit | 8780.0 | n/a |
| 2026-09-10 | Dickinson Andrew D | F · Tax / exercise payment | Common Stock | 1347.0 | 144.81 |
| 2026-09-10 | Dickinson Andrew D | M · Exercise / conversion | Common Stock | 2797.0 | n/a |
| 2026-09-10 | Dickinson Andrew D | M · Exercise / conversion | Restricted Stock Unit | 2797.0 | n/a |
| 2026-09-01 | O'Day Daniel Patrick | S · Sale | Common Stock | 1600.0 | 147.51 |
| 2026-09-01 | O'Day Daniel Patrick | S · Sale | Common Stock | 7992.0 | 148.36 |
| 2026-09-01 | O'Day Daniel Patrick | S · Sale | Common Stock | 5408.0 | 149.38 |
| 2026-08-26 | WELTERS ANTHONY | S · Sale | Common Stock | 4600.0 | 148.82 |
| 2026-08-26 | WELTERS ANTHONY | S · Sale | Common Stock | 6880.0 | 148.82 |
| 2026-08-26 | WELTERS ANTHONY | S · Sale | Common Stock | 3402.0 | 148.24 |
| 2026-08-26 | WELTERS ANTHONY | S · Sale | Common Stock | 3118.0 | 148.31 |
| 2026-08-26 | WELTERS ANTHONY | M · Exercise / conversion | Common Stock | 10282.0 | 61.35 |
| 2026-08-26 | WELTERS ANTHONY | M · Exercise / conversion | Common Stock | 7718.0 | 60.67 |
| 2026-08-26 | WELTERS ANTHONY | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 7718.0 | 0.0 |
| 2026-08-26 | WELTERS ANTHONY | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 10282.0 | 0.0 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Common Stock | 1658.0 | 67.45 |
| 2026-08-20 | Bluestone Jeffrey | S · Sale | Common Stock | 1658.0 | 145.73 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Common Stock | 26.0 | 67.45 |
| 2026-08-20 | Bluestone Jeffrey | S · Sale | Common Stock | 1816.0 | 144.92 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Common Stock | 1165.0 | 67.45 |
| 2026-08-20 | Bluestone Jeffrey | S · Sale | Common Stock | 1165.0 | 143.75 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Common Stock | 1816.0 | 67.45 |
| 2026-08-20 | Bluestone Jeffrey | S · Sale | Common Stock | 335.0 | 146.26 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Common Stock | 335.0 | 61.35 |
| 2026-08-20 | Bluestone Jeffrey | S · Sale | Common Stock | 26.0 | 146.36 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 4665.0 | 0.0 |
| 2026-08-20 | Bluestone Jeffrey | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 335.0 | 0.0 |
| 2026-08-17 | Mercier Johanna | S · Sale | Common Stock | 11470.0 | 138.04 |
| 2026-08-17 | Mercier Johanna | S · Sale | Common Stock | 16530.0 | 137.37 |
| 2026-08-17 | Mercier Johanna | M · Exercise / conversion | Common Stock | 1890.0 | 72.34 |
| 2026-08-17 | Mercier Johanna | M · Exercise / conversion | Common Stock | 23110.0 | 66.64 |
| 2026-08-17 | Mercier Johanna | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 1890.0 | 0.0 |
Identity & relationships
SEC issuer · 0000882095GILEAD SCIENCES, INC.
Gilead Sciences LtdGilead Sciences (Australia)Kite Pharma
- Legal Entity Identifier
- 549300WTZWR07K8MNV44
- GLEIF legal name
- GILEAD SCIENCES, INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-03-03T10:10:30Z
Search names and former names
View Wikidata identity and references ↗
- Gilead Sciences · alias · wikidata
- Gilead · alias · wikidata
- Gilead Sciences Ltd · subsidiary · wikidata
- NEXSTAR PHARMACEUTICALS LIMITED · subsidiary · wikidata
- VESTAR LIMITED · subsidiary · wikidata
- MAPLESTORE LIMITED · subsidiary · wikidata
- Gilead Sciences (Australia) · subsidiary · wikidata
- Kite Pharma · subsidiary · wikidata
- Kite Pharma Inc · subsidiary · wikidata
- GILEAD SCIENCES INC · former SEC name · 1994-02-14 to 2022-02-17
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $28.75B | $30.88B |
| 2023-12-31 | $27.12B | $29.98B |
| 2022-12-31 | $27.28B | $31.40B |
| 2021-12-31 | $27.30B | $33.95B |
| 2020-12-31 | $24.69B | $32.14B |
| 2019-12-31 | $22.45B | $29.58B |
| 2018-12-31 | $22.13B | $29.69B |
| 2017-12-31 | $26.11B | $35.89B |